Reduction of platelet aggregation induced by euglycaemic insulin clamp

Area of Science:

• Endocrinology
• Hematology
• Metabolic Research

Background:

• Platelet aggregation plays a crucial role in thrombosis and cardiovascular disease.
• The independent effect of insulin on platelet function, separate from its glucose-lowering effects, requires further investigation.

Purpose of the Study:

• To investigate the in vivo effect of serum insulin, independent of blood glucose levels, on platelet aggregation in healthy individuals.
• To determine if hyperinsulinemia influences platelet responsiveness to common agonists.

Main Methods:

• A 4-hour euglycaemic insulin clamp was performed, maintaining blood glucose at 5.0 mmol/l and insulin at 100 microU/ml.
• Platelet aggregation was measured using adenosine diphosphate (ADP), collagen, and epinephrine as agonists.
• Control experiments involved saline infusion with normal insulin and glucose levels.

Main Results:

• Platelet aggregation induced by ADP, collagen, and epinephrine was significantly reduced after 4 hours of hyperinsulinemia (p < 0.05).
• Specifically, aggregation decreased from 8.4% to 3.9% for ADP, 26.2% to 7.0% for collagen, and 31.8% to 9.1% for epinephrine.
• No significant changes in platelet aggregation were observed during saline infusion with normal insulin levels.

Conclusions:

• Hyperinsulinemia, under euglycaemic conditions, significantly inhibits platelet aggregation in vivo.
• Insulin possesses a direct, glucose-independent effect on reducing platelet responsiveness.